Octapharma

OCTAGAM

Manufacturer:

Octapharma

Octagam HCPCS:

J1568

HCPCS Code Descriptor:

Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg

Category:

J Code

Octagam NDCs:

68982-0850-05, 68982-0850-04, 68982-0840-05, 68982-0850-03, 68982-0840-04, 68982-0850-02, 68982-0840-03, 68982-0840-02, 68982-0850-01, 68982-0840-01

Primary Type:

Immunoglobulin

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

68982-0840-05

About Octagam:

OCTAGAM is an Immunoglobulin drug manufactured by Octapharma and administered via the Intravenous route of administration. The J Code: J1568 is aligned to the drug OCTAGAM.

OCTAGAM is a human immune globulin therapy indicated for the treatment of chronic immune thrombocytic pupura (ITP) and dermatomyositis (DM). OCTAGAM (J1568) is most commonly used in adult patients. Patients over the age of 65 may be at higher risk of thrombotic events and acute renal failure when using OCTAGAM.

ACCESS PRICING AND MORE BY REGISTERING

J1568 Added Date:

January 1, 2008

J1568 Effective Date:

January 1, 2008

J1568 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Octagam billing and coding information.
Our team did not identify a source for Octagam patient assistance information. Please reach out to our team if you feel that this is a mistake.
OCTAGAM prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for OCTAGAM. Please check back in a few weeks.